Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer
0 Views
administrator
07/14/23
In this segment, panelists discuss the number of early-phase clinical trials that have demonstrated impressive efficacy for next-generation ALK and EGFR inhibitors for patients with non-small cell lung cancer.
To view more from this discussion, visit http://www.onclive.com/peer-ex....change/nsclc-outcome
-
Category
Show more
Facebook Comments
No comments found